“…These include the presence, in the measured cell suspension, of both inflammatory cells and S-phase-arrested cells (that are considered as proliferating by single DNA FCM while they actually are not) and the impossibility (with the available mathematical models) of correctly evaluating the S-phase in aneuploid cases. A reliable evaluation of tumor growth will come from analysis of in vivo bromodeoxyuridine (BUdR) administration (Gratzner, 1982;Dolbeare et al, 1983;Wilson et al, 1985;Danova et al, 19866), as indicated in rapidly progressing studies of brain tumors (Hoshino, 1985(Hoshino, , 1986(Hoshino, , 1988(Hoshino, , 1989Danova et al, 19876, 1988;Wilson et al, 1988;Riccardi et al, 1988Riccardi et al, , 1989Assietti et al, 1990).…”